Free Trial

Cronos Group (CRON) Competitors

Cronos Group logo
$2.05 -0.02 (-0.97%)
Closing price 04:00 PM Eastern
Extended Trading
$2.07 +0.02 (+0.78%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRON vs. ACB, CGC, OGI, SNDL, TLRY, HCM, IMVT, KYMR, CRNX, and MOR

Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), HUTCHMED (HCM), Immunovant (IMVT), Kymera Therapeutics (KYMR), Crinetics Pharmaceuticals (CRNX), and MorphoSys (MOR). These companies are all part of the "pharmaceutical products" industry.

Cronos Group vs. Its Competitors

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.3% of Cronos Group shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cronos Group has a net margin of 39.69% compared to Aurora Cannabis' net margin of 1.32%. Aurora Cannabis' return on equity of 0.13% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group39.69% -0.07% -0.07%
Aurora Cannabis 1.32%0.13%0.10%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67

Cronos Group has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500.

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos Group$124.59M6.35$41.08M$0.1315.77
Aurora Cannabis$343.29M0.79$1.63M$0.1144.00

In the previous week, Cronos Group and Cronos Group both had 3 articles in the media. Cronos Group's average media sentiment score of 0.91 beat Aurora Cannabis' score of 0.53 indicating that Cronos Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Aurora Cannabis beats Cronos Group on 9 of the 15 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRON vs. The Competition

MetricCronos GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$798.36M$2.82B$5.74B$9.51B
Dividend YieldN/A1.78%4.60%3.99%
P/E Ratio15.779.0428.1120.03
Price / Sales6.35744.02461.37103.88
Price / Cash4,491.53166.2336.5559.01
Price / Book0.715.168.655.90
Net Income$41.08M$30.99M$3.25B$258.66M
7 Day Performance1.99%7.74%4.20%2.23%
1 Month Performance8.47%16.18%10.82%12.76%
1 Year Performance-15.29%-1.03%34.70%19.36%

Cronos Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRON
Cronos Group
2.0405 of 5 stars
$2.05
-1.0%
N/A-12.7%$798.36M$124.59M15.77450News Coverage
ACB
Aurora Cannabis
0.2832 of 5 stars
$4.70
+3.8%
N/A-16.5%$264.38M$246.72M42.731,130
CGC
Canopy Growth
0.3507 of 5 stars
$1.12
+2.8%
N/A-84.8%$205.93M$225.65M-0.283,150
OGI
Organigram Global
1.3259 of 5 stars
$1.46
+0.7%
N/A-7.1%$195.55M$117.47M14.60860Positive News
SNDL
SNDL
1.8885 of 5 stars
$1.58
+2.6%
$4.00
+153.2%
-30.8%$415.19M$671.81M-5.452,516News Coverage
Upcoming Earnings
TLRY
Tilray Brands
1.8105 of 5 stars
$0.67
+8.4%
$1.92
+184.6%
-60.7%$677.88M$788.94M-0.642,650Upcoming Earnings
Options Volume
HCM
HUTCHMED
2.7778 of 5 stars
$17.74
+0.9%
$19.00
+7.1%
-5.1%$3.09B$630.20M0.001,811Positive News
Analyst Forecast
IMVT
Immunovant
1.5976 of 5 stars
$17.70
-1.2%
$36.30
+105.1%
-34.4%$3.03BN/A-6.46120Positive News
Gap Down
KYMR
Kymera Therapeutics
3.0325 of 5 stars
$45.14
-2.3%
$59.11
+31.0%
+6.9%$2.94B$47.07M-14.56170Positive News
CRNX
Crinetics Pharmaceuticals
3.6711 of 5 stars
$30.95
-0.5%
$69.50
+124.6%
-43.1%$2.90B$1.04M-8.10210
MOR
MorphoSys
N/A$18.96
flat
N/AN/A$2.86B$238.28M-5.45730

Related Companies and Tools


This page (NASDAQ:CRON) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners